Table 1.
Results of radiation monotherapy for primary central nervous system lymphoma.
| First author (Group) |
Year (publication no.) |
Median survival (months) |
5-year survival (%) |
|---|---|---|---|
| Littman (Review) | 975 (150) | - | 6 |
| Leibel (Review) | 1987 (114) | 24 | 7 |
| Shibamoto (Kyoto) | 1990 (16) | 8 | 6 |
| Nelson (RTOG) | 1992 (41) | 12 | 28 (at 2 years) |
| Watne (Norway) | 1992 (15) | 19 | 13 |
| Ishikawa (Gunma) | 2003 (25) | 13* | 35 |
| Shibamoto (JASTRO) | 2005 (132) | 18 | 18 |
Kyoto, Kyoto University Hospital; RTOG, Radiation Therapy Oncology Group; Norway, Norwegian Radium Hospital; Gunma, Gunma University Hospital; JASTRO, Japanese Society for Therapeutic Radiology and Oncology CNS Lymphoma Study Group.
*For 33 patients, including 8 patients undergoing systemic chemotherapy without methotrexate.